Soluble CD137 as a potential biomarker for severe COVID-19

por Marques, Mariana de Oliveira, Abdo, André, Silva, Priscilla Brito, Silva Junior, Amilton, Alves, Lucas Bassolli de Oliveira, Costa, José Victor Gomes, Martin, Josiane, Bachour, Philip, Baiocchi, Otavio C.G.
Publicado 2022

Maternal Diet Supplementation with n-6/n-3 Essential Fatty Acids in a 1.2 : 1.0 Ratio Attenuates Metabolic Dysfunction in MSG-Induced Obese Mice

por Martin, Josiane Morais, Miranda, Rosiane Aparecida, Barella, Luiz Felipe, Palma-Rigo, Kesia, Alves, Vander Silva, Fabricio, Gabriel Sergio, Pavanello, Audrei, Franco, Claudinéia Conationi da Silva, Ribeiro, Tatiane Aparecida, Visentainer, Jesuí Vergílio, Banafé, Elton Guntendeorfer, Martin, Clayton Antunes, Mathias, Paulo Cezar de Freitas, de Oliveira, Júlio Cezar
Publicado 2016

Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial

por Veiga, Viviane C, Prats, João A G G, Farias, Danielle L C, Rosa, Regis G, Dourado, Leticia K, Zampieri, Fernando G, Machado, Flávia R, Lopes, Renato D, Berwanger, Otavio, Azevedo, Luciano C P, Avezum, Álvaro, Lisboa, Thiago C, Rojas, Salomón S O, Coelho, Juliana C, Leite, Rodrigo T, Carvalho, Júlio C, Andrade, Luis E C, Sandes, Alex F, Pintão, Maria C T, Castro, Claudio G, Santos, Sueli V, de Almeida, Thiago M L, Costa, André N, Gebara, Otávio C E, de Freitas, Flávio G Rezende, Pacheco, Eduardo S, Machado, David J B, Martin, Josiane, Conceição, Fábio G, Siqueira, Suellen R R, Damiani, Lucas P, Ishihara, Luciana M, Schneider, Daniel, de Souza, Denise, Cavalcanti, Alexandre B, Scheinberg, Phillip
Publicado 2021